BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36262954)

  • 1. An Adrenal SMARCB1/INI1 Deficient Proximal Epithelioid Sarcoma in a Middle-Aged Female: A Case Report.
    Brodie Z; McCartney E; Toledo S
    Cureus; 2022 Sep; 14(9):e29242. PubMed ID: 36262954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
    Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G
    Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SWI/SNF Chromatin-remodeling Complex Status in SMARCB1/INI1-preserved Epithelioid Sarcoma.
    Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Taguchi T; Iwamoto Y; Oda Y
    Am J Surg Pathol; 2018 Mar; 42(3):312-318. PubMed ID: 29309303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin-4 expression distinguishes SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas.
    Schaefer IM; Agaimy A; Fletcher CD; Hornick JL
    Mod Pathol; 2017 Apr; 30(4):539-548. PubMed ID: 28084340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SWI/SNF complex-deficient soft tissue neoplasms: An update.
    Schaefer IM; Hornick JL
    Semin Diagn Pathol; 2021 May; 38(3):222-231. PubMed ID: 32646614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic study of deciduoid mesothelioma using SMARCB1/INI1 immunohistochemistry and fluorescence in situ hybridization.
    Kawai T; Ogata S; Nakashima H; Urabe S; Murakami I; Hiroshima K
    Hum Pathol; 2019 Nov; 93():23-29. PubMed ID: 31445842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.
    Hornick JL; Dal Cin P; Fletcher CD
    Am J Surg Pathol; 2009 Apr; 33(4):542-50. PubMed ID: 19033866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of SMARCB1/INI1 protein in synovial sarcoma.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Matono H; Iwamoto Y; Taguchi T; Tsuneyoshi M
    Mod Pathol; 2010 Jul; 23(7):981-90. PubMed ID: 20305614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proximal-type Epithelioid Sarcoma of the Head and Neck (HN): A Study with Immunohistochemical and Molecular Analysis of SMARCB1.
    Frank R; Sadri N; Bhatti T; Biegel JA; Livolsi VA; Zhang PJ
    J Clin Exp Oncol; 2013; 2(2):. PubMed ID: 24308011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study.
    Espinosa I; D'Angelo E; De Brot L; Prat J
    Hum Pathol; 2023 May; 135():1-10. PubMed ID: 36863690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor.
    Duan Z; Yao K; Yang S; Qu Y; Ren M; Zhang Y; Fan T; Zhao H; Gao J; Feng J; Fan X; Qi X
    Mod Pathol; 2022 Dec; 35(12):1910-1920. PubMed ID: 35804041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic roles of SMARCB1/INI1 and its deficient tumors.
    Kohashi K; Oda Y
    Cancer Sci; 2017 Apr; 108(4):547-552. PubMed ID: 28109176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of retroperitoneal tumor displaying epithelial differentiation, prominent myxoid stroma and loss of INI1/SMARCB1.
    Rekhi B; Thomas A
    Pathologica; 2021 Dec; 113(6):456-462. PubMed ID: 34974552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis.
    Li L; Fan XS; Xia QY; Rao Q; Liu B; Yu B; Shi QL; Lu ZF; Zhou XJ
    Hum Pathol; 2014 Nov; 45(11):2247-54. PubMed ID: 25200863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMARCB1/INI1-deficient epithelioid and myxoid neoplasms in paratesticular region: Expanding the clinicopathologic and molecular spectrum.
    Yin X; Yang X; Wang S; Zhou J; Zhao M
    Ann Diagn Pathol; 2024 Feb; 68():152242. PubMed ID: 38039617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMARCB1/INI1-deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report.
    Fujita K; Mizuguchi K; Mori T; Shimoda T; Sakano K; Shimaguchi C; Ito A; Yoshimura K; Sakaguchi M; Imi T; Ikeda H
    Diagn Cytopathol; 2023 Oct; 51(10):E294-E300. PubMed ID: 37475580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SWI/SNF deficient central nervous system neoplasms.
    Cai C
    Semin Diagn Pathol; 2021 May; 38(3):167-174. PubMed ID: 33762087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.